✦ LIBER ✦

168 A phase II study of docetaxel, epirubicin, and cispiatin with G-CSF (ienograstim) support in patients with advanced ovarian cancer

✍ Scribed by R. Lalisang; F. Erdkamp; J. Wils; J. Vreeswijk; J. Wals; J. Stoot; Y. Groot; J. Smeets; H. van Geuns

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intensive weekly chemotherapy with docet

✍ Thomas Makatsoris; Pavlos Papakostas; Haralabos P. Kalofonos; Ioannis Xanthakis; 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 153 KB

Cisplatin — epirubicin — paclitaxel (PET

✍ Frasci, G.; Comella, P.; D'Aiuto, G.; Apicella, A.; Thomas, R.; Capasso, I.; Car 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 155 KB

682 - Phase I/II study of alternating do

✍ C. Kourousis; N. Androulakis; S. Kakolyris; P. Heras; N. Vardakis; A. Kotsakis; 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 390 KB

A phase I study of escalating doses of d

✍ Masters, G.A; Brockstein, B.E; Bertucci, D; Mani, S; Ratain, M.J 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 224 KB

Docetaxel and epirubicin compared with d

✍ Petrioli, R; Pascucci, A; Conca, R; Chiriacò, G; Francini, E; Bargagli, G; Fiasc 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 322 KB

Phase II study of dose-dense doxorubicin

✍ Jesús García-Mata; Andrés García-Palomo; Lourdes Calvo; Ramón Mel; Juan Jesús Cr 📂 Article 📅 2008 🏛 Springer Milan 🌐 Spanish ⚖ 240 KB